Skip to main content

Table 3 Gastrointestinal Symptom Rating Scale Abdominal Pain Subscore

From: A prospective, randomized, double-blind, placebo-controlled parallel-group dual site trial to evaluate the effects of a Bacillus coagulans-based product on functional intestinal gas symptoms

Visit

Gas Defense

Placebo

Day 0

Screen/Rand

3.17 ± 1.85 (29)

3.14 ± 1.48 (29)

Day 14

Mid-Study

2.10 ± 1.29 (29)

2.28 ± 1.51 (29)

Day 29

End-of-Study

1.59 ± 0.95 (29)

2.21 ± 1.45 (29)

Change from

Day 0 to Day 14

-1.07 ± 1.70 (29)

-0.86 ± 1.81 (29)

Change from

Day 0 to Day 29

-1.59 ± 1.70 (29)

-0.93 ± 1.67 (29)

  1. Values are expressed as mean ± standard deviation.
Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us